Cardiovascular Disease
AI and Multi-Omics Converge: Cardio Diagnostics Targets Earlier, More Precise Cardiac Insights
Cardio Diagnostics Holdings is leveraging artificial intelligence and multi-omic biomarkers to improve early detection and personalized treatment of cardiovascular disease, addressing a critical gap in traditional risk assessment.
Cardio Diagnostics Leverages AI and Multi-Omic Biomarkers to Combat Cardiovascular Disease
Cardio Diagnostics Holdings is advancing AI-driven blood tests for earlier, more personalized detection and management of cardiovascular disease, addressing the leading cause of death in the U.S.
Cardio Diagnostics Leverages AI and Genomics to Revolutionize Cardiovascular Disease Detection
Cardio Diagnostics Holdings (NASDAQ: CDIO) is advancing AI-powered solutions using simple blood tests to detect and manage cardiovascular disease, addressing the leading cause of death in the US.
American Heart Association Awards $15 Million to Research Early Detection of Heart Valve Disease
A new $15 million research initiative led by three major medical institutions aims to transform heart valve disease care by focusing on early detection and prevention strategies for a condition affecting over 80 million people worldwide.
Cardio Diagnostics Holdings Gains Attention for AI-Driven Cardiovascular Platform
Cardio Diagnostics Holdings is highlighted as a company to watch due to its AI-powered approach to cardiovascular disease prevention, detection, and management, integrating epigenetics and genetics for personalized insights.
Cardio Diagnostics Holdings Leverages AI and Epigenetics for Advanced Cardiovascular Disease Management
Cardio Diagnostics Holdings is advancing cardiovascular disease prevention and detection through an AI-driven platform that integrates genetics and epigenetics to provide personalized insights.
PCSK9 Inhibitor Shows Significant Cardiovascular Risk Reduction in High-Risk Patients Without Prior Heart Events
The VESALIUS-CV trial demonstrates that evolocumab reduces major cardiovascular events by 25% in patients with atherosclerotic disease or diabetes who haven't had prior heart attacks or strokes, potentially expanding preventive treatment options for millions at risk.
Sigyn Therapeutics Advances CardioDialysis™ to Address Cardiovascular Disease in Dialysis Patients
Sigyn Therapeutics is developing CardioDialysis™, a medical device that leverages existing dialysis infrastructure to treat cardiovascular disease in end-stage renal disease patients, who face a 67% mortality rate from heart conditions and limited benefit from traditional drug therapies.
Inaugural Jack Sarver Prizes Awarded to St. Louis and Dallas Researchers for Cardiovascular Disease Prevention Studies
Two scientists from Washington University and UT Southwestern received the first Jack Sarver Prizes for research addressing maternal mortality in Nigeria through aspirin prophylaxis and identifying genetic mechanisms linking liver disease to atherosclerosis.
Cardiovascular Complications Affect 1 in 7 Pregnancies as Risk Factors Rise Sharply
New research reveals cardiovascular complications impact 15% of pregnancies, driven by increasing rates of obesity, hypertension, diabetes and high cholesterol over the past two decades.
UCLA Researcher Peter Tontonoz to Receive 2025 American Heart Association Basic Research Prize for Lipid Metabolism Discoveries
Dr. Peter Tontonoz's groundbreaking research on cholesterol and lipid metabolism has transformed understanding of cardiovascular diseases and paved the way for new treatments beyond statins.
Childhood High Blood Pressure Linked to 40-50% Higher Risk of Early Cardiovascular Death
New research reveals that children with elevated blood pressure at age 7 face significantly increased risk of premature cardiovascular death by mid-50s, highlighting the critical importance of early blood pressure monitoring and heart-healthy habits.
Sigyn Therapeutics Expands Cardiovascular Disease Study to Target Lipoprotein Reduction
Sigyn Therapeutics plans a clinical feasibility study of its blood purification technology that could address cardiovascular disease in high-risk patients while potentially extending lives of end-stage renal disease patients and generating significant economic impact.
New High Blood Pressure Guideline Focuses on Prevention and Early Treatment to Combat CVD Risk
A joint guideline by the American Heart Association and the American College of Cardiology emphasizes early treatment and lifestyle changes to manage high blood pressure, aiming to reduce the risk of cardiovascular diseases and cognitive decline.
Excessive Screen Time Linked to Higher Cardiometabolic Risks in Youth, Study Finds
New research highlights the association between excessive screen time and increased cardiometabolic disease risks in children and young adults, emphasizing the need for balanced daily routines to protect long-term health.
Research Teams Awarded $10.5 Million to Explore AI's Role in Combating Cardiovascular Disease
Two research teams receive significant funding to investigate how artificial intelligence can enhance the detection and treatment of cardiovascular disease, offering potential breakthroughs in early diagnosis and emergency care.
Cardiovascular Disease Risk Factors on the Rise Despite Medical Advances
The American Heart Association's 2025 report highlights increasing risk factors for cardiovascular diseases, signaling a pressing public health challenge.
Shift in Heart Disease Deaths Highlights Advances and Emerging Challenges
Over the past 50 years, heart disease death rates have significantly decreased, with a shift from heart attacks to heart failure, arrhythmias, and hypertensive heart disease, reflecting medical advancements and emerging health challenges.
Study Links Microplastic Pollution in Coastal Waters to Increased Risk of Cardiometabolic Diseases
Residents of U.S. coastal counties with high levels of microplastic pollution in nearby waters face significantly higher rates of Type 2 diabetes, coronary artery disease, and stroke, highlighting the potential public health crisis posed by plastic pollution.
American Heart Association Launches Data Challenge to Uncover Inflammation's Role in Heart Disease
The American Heart Association has initiated the Systemic Inflammation Data Challenge to explore the connection between inflammation, marked by elevated hsCRP levels, and cardiovascular disease, aiming to improve health outcomes through advanced data science.
Heart Disease Deaths Rise as Risk Factors Reach Alarming Levels
Cardiovascular disease deaths increased by over 10,000 in 2022, while obesity, diabetes, and high blood pressure rates continue climbing. Healthcare costs related to heart disease are projected to surge 300% by 2050, highlighting a growing public health crisis.
Star-Studded Red Dress Concert Highlights Critical Women's Heart Health Crisis
Sharon Stone hosts a major charity concert and fashion event in New York City to spotlight cardiovascular disease as the leading killer of women, featuring performances by Sara Bareilles and Suki Waterhouse, emphasizing the ongoing need for awareness and research in women's heart health.
Major Retailers Join Forces to Combat Rising Cardiovascular Disease Crisis
As cardiovascular disease threatens to affect 61% of U.S. adults in the next 30 years, national retailers launch collaborative campaigns during American Heart Month to support critical research and health initiatives.